assembly_id	genome_id	genome_def	crispr_array_locus_merge	crispr_array_location_merge	crispr_locus_id	crispr_pred_method	array_in_prot	prot_within_array_20000	prot_in_genome	crispr_type_by_cas_prot	consensus_repeat	repeat_length	self-targeting_spacer_number	self-targeting_target_number	spacer_location	protospacer_location	repeat_type	spacer_locus_num	spacer_num	correct_crispr_type	genome_cas_prots	unknown_protein_around_crispr	L10	L10_domain	L9	L9_domain	L8	L8_domain	L7	L7_domain	L6	L6_domain	L5	L5_domain	L4	L4_domain	L3	L3_domain	L2	L2_domain	L1	L1_domain	R1	R1_domain	R2	R2_domain	R3	R3_domain	R4	R4_domain	R5	R5_domain	R6	R6_domain	R7	R7_domain	R8	R8_domain	R9	R9_domain	R10	R10_domain
GCF_001687565.2_ASM168756v2	NZ_CP016534	Planococcus antarcticus DSM 14505 chromosome, complete genome	1	2026908-2028398	1,1,1	CRISPRCasFinder,CRT,PILER-CR	no	cas2,cas1,cas9	cas3,csa3,cas2,cas1,cas9,DinG,DEDDh	Type II-B,Type II-A, or Type II-C?,Type II-C, Type II-B	GTTTTACTACTCTCTAAAATTACATTGGTCTAAAAC,GTTTTACTACTCTCTAAAATTACATTGGTCTAAAAC,GTTTTACTACTCTCTAAAATTACATTGGTCTAAAAC	36,36,36	1	1	2027803-2027833	NZ_CP016536.1_4564-4594	NA:NA:NA	22,22,21	22	TypeII-B,TypeII-A,orTypeII-C?,TypeII-C,TypeII-B	cas3,csa3,cas2,cas1,cas9,DinG,DEDDh	NA|208aa|up_4|NZ_CP016534.2_2022338_2022962_-,NA|149aa|up_3|NZ_CP016534.2_2023697_2024144_+,NA|223aa|up_1|NZ_CP016534.2_2024860_2025529_-,NA|289aa|down_0|NZ_CP016534.2_2028418_2029285_-,NA|285aa|down_4|NZ_CP016534.2_2035068_2035923_+,NA|120aa|down_5|NZ_CP016534.2_2036346_2036706_+,NA|120aa|down_8|NZ_CP016534.2_2038141_2038501_+	NA|257aa|up_9|NZ_CP016534.2_2017403_2018174_+	PRK06526, PRK06526, transposase; Provisional	NA|173aa|up_8|NZ_CP016534.2_2018168_2018687_-	PRK09415, PRK09415, RNA polymerase factor sigma C; Reviewed	NA|206aa|up_7|NZ_CP016534.2_2019746_2020364_+	cd03768, SR_ResInv, Serine Recombinase (SR) family, Resolvase and Invertase subfamily, catalytic domain; members contain a C-terminal DNA binding domain	NA|201aa|up_6|NZ_CP016534.2_2020523_2021126_+	pfam18153, S_2TMBeta, SMODS-associating 2TM, beta-strand rich effector domain	NA|298aa|up_5|NZ_CP016534.2_2021137_2022031_-	cd05400, NT_2-5OAS_ClassI-CCAase, Nucleotidyltransferase (NT) domain of 2'5'-oligoadenylate (2-5A)synthetase (2-5OAS) and class I CCA-adding enzyme	NA|208aa|up_4|NZ_CP016534.2_2022338_2022962_-	NA	NA|149aa|up_3|NZ_CP016534.2_2023697_2024144_+	NA	NA|109aa|up_2|NZ_CP016534.2_2024161_2024488_+	pfam00157, Pou, Pou domain - N-terminal to homeobox domain	NA|223aa|up_1|NZ_CP016534.2_2024860_2025529_-	NA	NA|382aa|up_0|NZ_CP016534.2_2025706_2026851_+	PHA02517, PHA02517, putative transposase OrfB; Reviewed	NA|289aa|down_0|NZ_CP016534.2_2028418_2029285_-	NA	cas2|103aa|down_1|NZ_CP016534.2_2029281_2029590_-	COG3512, COG3512, CRISPR-associated protein, Cas2 homolog [Defense mechanisms]	cas1|295aa|down_2|NZ_CP016534.2_2029607_2030492_-	cd09720, Cas1_II, CRISPR/Cas system-associated protein Cas1	cas9|1334aa|down_3|NZ_CP016534.2_2030488_2034490_-	TIGR01865, conserved_hypothetical_protein, CRISPR subtype II/NMENI RNA-guided endonuclease Cas9/Csn1	NA|285aa|down_4|NZ_CP016534.2_2035068_2035923_+	NA	NA|120aa|down_5|NZ_CP016534.2_2036346_2036706_+	NA	NA|116aa|down_6|NZ_CP016534.2_2036706_2037054_+	COG2026, RelE, Cytotoxic translational repressor of toxin-antitoxin stability system [Translation, ribosomal structure and biogenesis / Cell division and chromosome partitioning]	NA|108aa|down_7|NZ_CP016534.2_2037333_2037657_+	pfam06877, RraB, Regulator of ribonuclease activity B	NA|120aa|down_8|NZ_CP016534.2_2038141_2038501_+	NA	NA|108aa|down_9|NZ_CP016534.2_2038497_2038821_+	COG2944, COG2944, Predicted transcriptional regulator [Transcription]
